Table 3.
Secondary outcome measures at the 6- to 10-week follow-up.a
| Characteristics | Intervention | Usual care | P value for difference crude | P value for difference adjustedb | |||||||||||||
|
|
Values | Change from baseline | Values | Change from baseline |
|
|
|||||||||||
| Risk factors |
|
||||||||||||||||
|
|
SBPc (mm Hg), mean (SD) | 123.6 (14.8) | −25.3 (27.4) | 127.1 (13.3) | −16.5 (27.4) | .08 | .02 | ||||||||||
|
|
DBPd (mm Hg), mean (SD) | 75.3 (10.0) | −13.4 (15.6) | 77.8 (8.7) | −9.1 (13.4) | .11 | .05 | ||||||||||
|
|
BMI (kg/m2), median (IQR) | 26.3 (24.0 to 29.0) | −0.3 (−1.1 to 0.3) | 27.0 (24.3 to 29.9) | −0.2 (−1.3 to 0.3) | .77 | .39e | ||||||||||
|
|
Total cholesterol (mmol/L), mean (SD) | 3.3 (0.8) | −1.5 (1.1) | 3.3 (0.6) | −1.6 (0.9) | .48 | .37 | ||||||||||
|
|
LDLf-cholesterol (mmol/L), mean (SD) | 1.5 (0.6) | −1.4 (0.9) | 1.5 (0.4) | −1.5 (0.8) | .28 | .24 | ||||||||||
|
|
HDLg-cholesterol (mmol/L), median (IQR) | 1.1 (0.9 to 1.5) | 0.1 (−0.1 to 0.2) | 1.2 (1.0 to 1.5) | 0.1 (−0.1 to 0.3) | .80 | .93 | ||||||||||
|
|
Triglycerides (mmol/L), median (IQR) | 1.0 (0.8 to 1.5) | −0.3 (−0.8 to 0.0) | 1.1 (0.8 to 1.4) | −0.3 (−0.7 to 0.0) | .93 | .99 | ||||||||||
|
|
Fasting plasma glucose (mmol/L), median (IQR) | 6.1 (5.8 to 6.8) | −1.4 (−3.3 to −0.3) | 6.2 (5.6 to 7.0) | −0.9 (−2.8 to −0.2) | .81 | .47 | ||||||||||
| Self-reported parameters, mean (SD) | |||||||||||||||||
|
|
Vegetable consumption | 2.2 (0.7) | 0.3 (0.8) | 2.2 (0.7) | 0.4 (1.1) | .74 | .65 | ||||||||||
|
|
Fruit consumption | 2.3 (0.7) | 0.6 (1.0) | 2.3 (0.7) | 0.5 (1.1) | .29 | .36 | ||||||||||
|
|
Fish consumption | 2.1 (1.0) | 0.9 (1.1) | 2.0 (0.9) | 0.8 (1.1) | .40 | .18 | ||||||||||
|
|
Consumption of sweets | 2.3 (0.9) | 0.3 (0.9) | 2.3 (0.9) | 0.5 (1.1) | .27 | .22 | ||||||||||
|
|
Healthy diet index | 8.9 (2.0) | 2.2 (2.3) | 8.8 (1.7) | 2.1 (2.6) | .82 | .77 | ||||||||||
aNumbers are presented as mean differences (SD), median differences (IQR), and P values. Crude and adjusted P values are shown for the differences in mean or median change (δ) between baseline and 6- to 10-week follow-up, comparing the intervention and usual care groups.
bAdjusted for gender, age, weight, previous heart disease, and smoking status at the time of the index event.
cSBP: systolic blood pressure.
dDBP: diastolic blood pressure.
eNot adjusted for weight.
fLDL: low-density lipoprotein.
gHDL: high-density lipoprotein.